Understand the source comparison
Best Peptides for Workplace Injury Recovery: Comparison
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin signaling Tendon tears, ligament sprains, chronic tendinopathies 200–400 mcg/day subcutaneous Strong preclinical (rodent models), no human RCTs Gold standard for tendon/ligament injuries with vascular limit
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis, FAK-paxillin signaling
- Tendon tears, ligament sprains, chronic tendinopathies
- 200–400 mcg/day subcutaneous
- Strong preclinical (rodent models), no human RCTs
- Gold standard for tendon/ligament injuries with vascular limitations
- TB-500 (Thymosin Beta-4)
- Actin polymerization, cell migration, keratinocyte activation
- Muscle strains, dermal wounds, fascial tears
- 2–5 mg twice weekly for 4–6 weeks
- Moderate preclinical, limited human case reports
- Best compound for muscle and soft tissue with adequate blood supply
- Thymalin
- T-cell modulation, cytokine regulation (IL-6, TNF-alpha reduction)
- Injuries with excessive inflammation, autoimmune flare overlap
- 5–10 mg administered 1–2 times weekly
- Emerging preclinical, primarily immune-focused studies
- Adjunct therapy for inflammatory control, not primary healing agent
- MK 677 (Ibutamoren)
- Growth hormone secretagogue, IGF-1 elevation
- Systemic recovery, muscle preservation during immobilization
- 12.5–25 mg orally once daily
- Moderate (Phase II human trials for muscle wasting)
- Indirect benefit through anabolic signaling; not injury-site-specific
- Hexarelin
- GH pulse stimulation, cardioprotective effects
- Muscle atrophy prevention, systemic recovery support
- 100–200 mcg 1–2 times daily
- Limited preclinical, some cardiac trial data
- Secondary option for muscle preservation; weaker tissue repair evidence than TB-500